Search

Memorial Sloan Kettering Cancer Center (MSK) has appointed Atefeh “Atti” Riazi as Chief Information Officer (CIO). In this role, Ms. Riazi will develop and implement an enterprise-wide, long-term strategic information technology (IT) plan and oversee the integration of data and technology resources across the organization.

… Thursday, January 30, 2020 Atefeh Riazi Atefeh Riazi Memorial Sloan Kettering Cancer Center (MSK) has appointed Atefeh “Atti” Riazi as Chief Information Officer (CIO), effective February 3. In this role, Ms. Riazi will develop and implement an enterprise-wide, long-term strategic information technology

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, January 4, 2024 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Omar Abdel-Wahab Received the William Dameshek Prize from the American Society of Hematology Omar Abdel-Wahab, MD , leukemia specialist, Chair of the Molecular Pharmacology at the 

Scientists are learning that — in a literal sense — metastasis is wound healing gone wrong.

… Monday, January 13, 2020 Summary Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to coopt natural wound-healing pathways. The findings provide a new way of looking at metastasis and its possible treatment

Read about an MSK pilot study that could help patients get better sleep in the hospital overnight.

… Thursday, August 15, 2024 The constant beeping of machines. The frequent middle-of-the-night interruptions for blood draws and blood pressure checks. These are some of Luke Weber’s most vivid memories of being a 9-year-old getting treated for a rare pediatric cancer at  MSK Kids . “It felt like they

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.

… Tuesday, June 26, 2018 Summary Scientists are learning that inflammation can play a role in cancer development. This is one example of how the environment surrounding an abnormal cell can influence its fate. Growing up, Philipp Niethammer learned from his mother to never scratch his moles. “I am not

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas Research Network.

… Wednesday, May 1, 2013 Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center

Today, after a yearlong review and collaborative process, Miami Cancer Institute at Baptist Health South Florida became a full member of the Memorial Sloan Kettering (MSK) Cancer Alliance. Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative initiative that aims to improve the quality of care and outcomes for people with cancer in community settings.

… Thursday, January 26, 2017 Today, after a yearlong review and collaborative process, Miami Cancer Institute at Baptist Health South Florida became a full member of the Memorial Sloan Kettering (MSK) Cancer Alliance . Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative

Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.

… Thursday, July 23, 2020 Summary Scientists at the Sloan Kettering Institute , the Koch Institute at MIT , and the Klarman Cell Observatory at the Broad Institute have identified an unusual cell state that emerges early in tumor evolution and supports a cancer’s ability to outwit chemotherapy. Cancer’

A unique collaboration among physician-scientists at Memorial Sloan Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. The study, published in the journal Cancer Cell, provides a previously unavailable genomic analysis whose scope and size offers new insight leading to more effective diagnostic tests as well as future treatment options for prostate cancer patients.

… Thursday, June 24, 2010 A unique collaboration among physician-scientists at Memorial Sloan Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. “Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients

When Dennis Flaherty was diagnosed with stage 4 kidney cancer, he knew he wanted to be treated at MSK. His story illustrates why U.S. News & World Report ranked MSK the top hospital in the country for urology care in 2023.

… Monday, March 4, 2024 When Dennis Flaherty was told he had stage 4 kidney cancer in February 2021, the doctor who diagnosed him at a local hospital on Long Island suggested he get his affairs in order. But from the moment he learned he had cancer, Dennis knew he wanted to be treated at Memorial Sloan